NSDHL anticorps
Aperçu rapide pour NSDHL anticorps (ABIN6989853)
Antigène
Voir toutes NSDHL AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Réactivité croisée
- Humain, Rat
-
Purification
- Purified by Protein A.
-
Immunogène
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-240 of human NSDHL (NP_057006.1).
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB 1:300-5000
IF(ICC) 1:50-200
IF() -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C for 12 months.
-
Date de péremption
- 12 months
-
-
- NSDHL (NAD(P) Dependent Steroid Dehydrogenase-Like (NSDHL))
-
Autre désignation
- NSDHL
-
Sujet
-
Synonyms: NSDHL,H105E3,SDR31E1,XAP104
Background: The protein encoded by this gene is localized in the endoplasmic reticulum and is involved in cholesterol biosynthesis. Mutations in this gene are associated with CHILD syndrome, which is a X-linked dominant disorder of lipid metabolism with disturbed cholesterol biosynthesis, and typically lethal in males. Alternatively spliced transcript variants with differing 5' UTR have been found for this gene.
-
ID gène
- 50814
-
UniProt
- Q15738
Antigène
-